InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: Kentucky123 post# 103419

Saturday, 04/29/2017 4:40:38 PM

Saturday, April 29, 2017 4:40:38 PM

Post# of 463580
This is not a rebuttal; a presentation of hard data.

Take the time, if you will, to ponder the copious data presented in this Anavex slide show, presented at a major neurological symposium:
http://www.anavex.com/my_uploads/CTAD-Anavex-December-2016.pdf

First (if you care not to read and comprehend the entire presentation), note the safety of Anavex 2-73, the absence of disqualifying or severe adverse effects, side effects, on page 16.

Then, skip to the chart on page 25, and note the restoration of measured cognitive function (electrochemically) on page 25.

No other drug or clinial trial has ever been able to reverse and/or restore normalized cognition in Alzheimer's patients. Anavex 2-73 did that --- without any of the severe side effects so common in neurological agents. That's the Anavex "story," and it's not fiction.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News